ArticleNature medicine2025
Changing climate and socioeconomic factors contribute to global antimicrobial resistance.
Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Five years of wastewater surveillance reveal COVID-19-Associated amplification and seasonal shifts inOne health (Amsterdam, Netherlands) · 2026Article
- Article
- Agricultural Pesticide Exposure and Antimicrobial Resistance inMicroorganisms · 2026Article
- Climate change and antimicrobial resistance.Nature reviews. Microbiology · 2026Review
- Ambient temperature variations and antimicrobial resistance: a multicountry analysis of non-linear relationships and temperature thresholds.BMJ global health · 2026Article
- Eco-Geography Reverses Dominant AMR Reservoirs in Klebsiella pneumoniae: Integron-Rich Mobilomes and Cross-Niche Connectivity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- A novel penicillin-binding protein inhibitor with unprecedented intracellular activity eradicates multiple pathogenic bacteria.PLoS pathogens · 2026Article
- Editorial: Antimicrobial resistance in aquatic environments - Bridging surveillance, ecology, and one health action.One health (Amsterdam, Netherlands) · 2026Article
- Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update.Nature medicine · 2026Article
- Epidemiology, Clinical Microbiology and Antimicrobial Therapy: A Shared Effort Against Infectious Diseases.Antibiotics (Basel, Switzerland) · 2026Article
- Ward microclimate and procedural factors as predictors for CRAB environmental contamination in ICUs: a longitudinal monitoring study.Antimicrobial resistance and infection control · 2026Article
- Challenges for the effectiveness of infectious disease interventions during global change.Communications health · 2026Article
- Managing antimicrobial resistance in a changing climate: Insights from a workshop.Journal of public health in Africa · 2026Article
- Characterization and diversity of defense systems inFrontiers in immunology · 2026Article
- Standard Treatment Workflows: scaling system-compatible approaches to rational antibiotic use.Frontiers in medicine · 2026Article
- Distribution and antibiotic resistance analysis of clinically isolated bacteria at a national regional cardiovascular medical center, 2018-2024.BMC infectious diseases · 2025Article
- Association between antibiotic resistance and air pollution and climate factors in China: A multivariable spatial-temporal analysis.One health (Amsterdam, Netherlands) · 2025Article
- Area-level socioeconomic status inequalities shape patterns of antimicrobial resistance in China, 2014-2023: a Bayesian spatiotemporal modelling analysis.The Lancet regional health. Western Pacific · 2025Article
- Antibiotic prescribing trends among Iranian GPs during COVID-19: a longitudinal analysis of antimicrobial resistance risks.BMC infectious diseases · 2025Article
- Characteristics and Influencing Factors of Antimicrobial Resistance inChina CDC weekly · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Climate change poses substantial challenges in containing antimicrobial resistance (AMR) from a One Health perspective. Using 4,502 AMR surveillance records involving 32 million tested isolates from 101 countries (1999-2022), we analyzed the impact of socioeconomic and environmental factors on AMR. We also established forecast models based on several scenarios, considering antimicrobial consumption reduction, sustainable development initiatives and different shared socioeconomic pathways under climate change. Our findings reveal growing AMR disparities between high-income countries and low- and middle-income countries under different shared socioeconomic pathway scenarios. By 2050, compared with the baseline, sustainable development efforts showed the most prominent effect by reducing AMR prevalence by 5.1% (95% confidence interval (CI): 0.0-26.6%), surpassing the effect of antimicrobial consumption reduction. Key contributors include reducing out-of-pocket health expenses (3.6% (95% CI: -0.5 to 21.4%)); comprehensive immunization coverage (1.2% (95% CI: -0.1% to 8.2%)); adequate health investments (0.2% (95% CI: 0.0-2.4%)) and universal access to water, sanitation and hygiene services (0.1% (95% CI: 0.0-0.4%)). These findings highlight the importance of sustainable development strategies as the most effective approach to help low- and middle-income countries address the dual challenges of climate change and AMR.
Indexed as
Identifiers
40295742What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.